Account
The Laughing Cow assigns media mandate to PHD India
NEW DELHI: French cheese brand The Laughing Cow has assigned its media duties to PHD Media.
Part of The Bel Group, The Laughing Cow was launched in Mumbai and Bengaluru in October 2018. The brand said PHD’s data centric and uniquely innovative approach to media and communication will help amplify its presence in the Indian market.
Fromageries Bel India commercial director Alamjit Singh Sekhon said, “India is a key focus market for the Bel Group. Our range of delicious cheese under The Laughing Cow Brand has a taste that caters to the Indian palate. The entire range is nutritious, being made from cows’ milk with added fortification. We are confident that this partnership will help accelerate our journey in India and grow the cheese category by creating impactful brand awareness.”
PHD Media India CEO Monaz Todywalla said, “This is a major win for us, and we’re looking forward to making strides in the dynamic FMCG segment which is always an exciting prospect because of the sheer volume of opportunities out there. The Laughing Cow is an iconic cheese brand and we are delighted to win the media mandate in India. We are confident that this will be a journey of mutual growth and are eager to get started on a thoughtful, data-driven storytelling strategy for the brand.”
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
